Newsbenzinga
Vertex Says Casgevy Label Expansion Opens Treatment to 5,500 More Us Children
· Published
Article summary
FDA expands Vertex Casgevy label to patients aged 2 and older, making about 5,500 more U.S. children eligible for the therapy.
An excerpt from the original article.
Comments —
Loading comments…